Park, Changhee http://orcid.org/0000-0002-7125-9795
Lee, Ho Sup
Kang, Ka-Won http://orcid.org/0000-0003-1462-0502
Lee, Won-Sik
Do, Young Rok
Kwak, Jae-Yong http://orcid.org/0000-0002-8070-4002
Shin, Ho-Jin
Kim, Sung-Yong
Yi, Jun Ho
Lim, Sung-Nam
Lee, Jeong-Ok
Yang, Deok-Hwan http://orcid.org/0000-0002-8167-8520
Jang, Hun
Choi, Byoungsan
Lim, Jiwoo
Sun, Choong Hyun
Byun, Ja Min http://orcid.org/0000-0003-1780-5553
Yoon, Sung-Soo http://orcid.org/0000-0003-2591-7459
Koh, Youngil http://orcid.org/0000-0002-4750-931X
Funding for this research was provided by:
AstraZeneca Korea (ESR-18-13701)
Celltrion Healthcare Co., Ltd Samyang Holdings
Article History
Received: 12 September 2023
Accepted: 20 March 2024
First Online: 30 March 2024
Competing interests
: C.H.S. and Y.K. are founder and stockholder of GenomeOpinion Incorporation. J.L. is employee of GenomeOpinion Incorporation. H.J. and B.C. are employee of PROTEINA corporation. The other authors have no conflict of interest.